The effect of prolonged duration of untreated depression on antidepressant treatment outcome

Journal of Affective Disorders

Volumn 145, Issue 1, 2013, Pages 42-48

  Bukh, Jens Drachmann ^a   Bock, Camilla ^a   Vinberg, Maj ^a   Kessing, Lars Vedel ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Depression; Duration of untreated illness; Remission

Indexed keywords

CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; COMORBIDITY; DEPRESSION; DISEASE REGISTRY; DSM-IV; DURATION OF UNTREATED ILLNESS; FEMALE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; REMISSION; RISK ASSESSMENT; STRUCTURED INTERVIEW; TIME TO TREATMENT; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; DELAYED DIAGNOSIS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; REMISSION INDUCTION; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872847462     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.07.008     Document Type: Article

References (26)

1. A.C. Altamura, B. Dell'osso, E. Mundo, and L. Dell'Osso Duration of untreated illness in major depressive disorder: a naturalistic study International Journal of Clinical Practice 61 2007 1697 1700
2. A.C. Altamura, B. Dell'osso, S. Vismara, and E. Mundo May duration of untreated illness influence the long-term course of major depressive disorder? European Psychiatry 23 2008 92 96
3. N.C. Andreasen, J. Endicott, R.L. Spitzer, and G. Winokur The family history method using diagnostic criteria. Reliability and validity Archives of General Psychiatry 34 1977 1229 1235
4. J.D. Bukh, C. Bock, M. Vinberg, T. Werge, U. Gether, and L.V. Kessing No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment European Neuropsychopharmacology 20 2010 327 335
5. J. de Diego-Adelino, M.J. Portella, D. Puigdemont, R. Perez-Egea, E. Alvarez, and V. Perez A short duration of untreated illness (DUI) improves response outcomes in first-depressive episodes Journal of Affective Disorders 120 2010 221 225
6. B. Dell'osso, and A.C. Altamura Duration of untreated psychosis and duration of untreated illness: new vistas CNS Spectrums 15 2010 238 246
7. R.S. Duman, and L.M. Monteggia A neurotrophic model for stress-related mood disorders Biological Psychiatry 59 2006 1116 1127
8. H.J. Eysenck, and S.G.B. Eysenck The Manual of the Eysenck Personality Questionnaire 1975 Hodder and Stoughton London
9. M.B. First, M. Gibbon, R.L. Spitzer, J.B.W. Williams, and L.S Benjamin The Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) 1997 American Psychiatric Press Washington
10. L.A. Goodman, and W.H. Kruskall Measures of association for cross-classification Journal of the American Statistical Association 63 1954 732 764
11. N. Gormley, D. O'Leary, and F. Costello First admissions for depression: is the 'no-treatment interval' a critical predictor of time to remission? Journal of Affective Disorders 54 1999 49 54
12. M. Hamilton A rating scale for depression Journal of Neurology, Neurosurgery, and Psychiatry 23 1960 56 62
13. S. Kisely, A. Scott, J. Denney, and G. Simon Duration of untreated symptoms in common mental disorders: association with outcomes: International study British Journal of Psychiatry 189 2006 79 80
14. G.M. MacQueen Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder Journal of Psychiatry and Neuroscience 34 2009 343 349
15. P. Munk-Jorgensen, and P.B. Mortensen The Danish Psychiatric Central Register Danish Medical Bulletin 44 1997 82 84
16. M. Nordentoft, P. Jeppesen, L. Petersen, M. Bertelsen, and A. Thorup The rationale for early intervention in schizophrenia and related disorders Early Intervention in Psychiatry 3 Suppl. 1 2009 S3 S7
17. A. Okuda, T. Suzuki, T. Kishi, Y. Yamanouchi, K. Umeda, H. Haitoh, S. Hashimoto, N. Ozaki, and N. Iwata Duration of untreated illness and antidepressant fluvoxamine response in major depressive disorder Psychiatry and Clinical Neurosciences 64 2010 268 273
18. E.S. Paykel The interview for recent life events Psychological Medicine 27 1997 301 310
19. M.A. Posternak, D. Young, T. Sheeran, I. Chelminski, C.L. Franklin, and M. Zimmerman Assessing past treatment history: test-retest reliability of the treatment response to antidepressant questionnaire Journal of Nervous and Mental Disease 192 2004 95 102
20. M.A. Posternak, and M. Zimmerman How accurate are patients in reporting their antidepressant treatment history? Journal of Affective Disorders 75 2003 115 124
21. H.A. Sackeim The definition and meaning of treatment-resistant depression Journal of Clinical Psychiatry 62 Suppl. 16 2001 10 17
22. R.M. Sapolsky The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death Biological Psychiatry 48 2000 755 765
23. J. Scott, D. Eccleston, and R. Boys Can we predict the persistence of depression? The British Journal of Psychiatry 161 1992 633 637
24. Y.I. Sheline, M. Sanghavi, M.A. Mintun, and M.H. Gado Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression Journal of Neuroscience 19 1999 5034 5043
25. J.K. Wing, T. Babor, T. Brugha, J. Burke, J.E. Cooper, R. Giel, A. Jablenski, D. Regier, and N. Sartorius SCAN. Schedules for clinical assessment in neuropsychiatry Archives of General Psychiatry 47 1990 589 593
26. M. Zimmerman, J.I. Mattia, and M.A. Posternak Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? American Journal of Psychiatry 159 2002 469 473